Imricor Medical Systems, Inc. (ASX:IMR – Get Free Report) insider Peter McGregor bought 100,000 shares of the stock in a transaction on Tuesday, May 7th. The shares were acquired at an average cost of A$0.48 ($0.32) per share, for a total transaction of A$48,400.00 ($32,052.98).
Peter McGregor also recently made the following trade(s):
- On Wednesday, February 28th, Peter McGregor 78,271 shares of Imricor Medical Systems stock.
Imricor Medical Systems Price Performance
The company has a debt-to-equity ratio of 59.20, a quick ratio of 4.33 and a current ratio of 0.86.
Imricor Medical Systems Company Profile
Imricor Medical Systems, Inc, a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator.
Read More
- Five stocks we like better than Imricor Medical Systems
- What Are Dividends? Buy the Best Dividend Stocks
- Roblox: The Bottom Just Fell Out of the Metaverse
- Health Care Stocks Explained: Why You Might Want to Invest
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Why is the Ex-Dividend Date Significant to Investors?
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Imricor Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imricor Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
